IP Library Granted Patent US 9,820,488
Granted Patent B2
US 9,820,488 · App. 15/030,476 · Granted Nov 21, 2017

Compounds for the control of endoparasites

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,820,488
App. No.
15/030,476
Granted
Nov 21, 2017
Kind
B2
Abstract

The invention relates to compounds of the general formula (I) wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites in warm-blooded animals.

Claims (69)

1. A compound of formula

wherein Z 1 and Z 2 are each independently N or CR 1′ ;

R 1 and R 1′ are each independently of the other H, halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 3 -haloalkoxyl, C 1 -C 4 -alkylthio, halo-C 1 -C 4 -alkylthio, SF 5 , amino, N-mono- or N,N-di-C 1 -C 4 -alkylamino, aminosulfonyl, N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl, N-mono- or N,N-di-halo-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonylamino, halo-C 1 -C 4 -alkylsulfonyl, halo-C 1 -C 4 -alkylsulfinyl, halo-C 1 -C 4 -alkylsulfonylamino or benzylsulfonylamino;

Q is Ar 1 or —C(O)—(O) m —R 2 ;

m is 0 or 1; R 2 is C 1 -C 6 -alkyl or C 3 -C 8 -cycloalkyl;

Ar 1 is (i) phenyl which is substituted by 1 to 2 same or different substituents selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxyl, C 1 -C 4 -alkylthio, halo-C 1 -C 4 -alkylthio, SF 5 , amino, N-mono- or N,N-di-C 1 -C 4 -alkylamino, aminosulfonyl, N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl, N-mono- or N,N-di-halo-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonylamino, benzylsulfonylamino, halo-C 1 -C 4 -alkylsulfonyl, halo-C 1 -C 4 -alkylsulfinyl and halodioxolyl; or is (ii) heteroaryl selected from the group consisting of 2-, 3- or 4-pyridyl and 2- or 3-thiophenyl which is each unsubstituted or substituted by methyl, ethyl, halogen, CF 3 or carboxy;

Ar 2 is phenyl which is substituted by 1 to 3 same or different substituents selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkylthio, halo-C 1 -C 4 -alkylthio, SF 5 , amino, N-mono- or N,N-di-C 1 -C 4 -alkylamino, aminosulfonyl, N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl, N-mono- or N,N-di-halo-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonylamino, benzylsulfonylamino, halo-C 1 -C 4 -alkylsulfonyl, halo-C 1 -C 4 -alkylsulfinyl and halodioxolyl;

L 1 is a bifunctional linker radical of formula

L 2 is a bifunctional linker radical of formula

A and B are each independently C 3 -C 8 -hetero-cycloalkylene or C 5 -C 10 -hetero-bicycloalkylene comprising two N-atoms, respectively which is each unsubstituted or substituted by C 1 -C 2 -alkyl;

A 1 , A 2 , and B 2 are each independently C 3 -C 8 -hetero-cycloalkylene comprising a N-atom, respectively;

R and R′ are each independently of the other H or C 1 -C 4 -alkyl;

or a physiologically acceptable salt thereof.

2. The compound according to claim 1 , wherein R 1 and R 1′ are each independently of the other H, cyano, methyl or methoxy.

3. The compound according to claim 1 , wherein Z 1 is N and Z 2 is CR 1′ .

4. The compound of formula (I) according to claim 3 , wherein Q is Ar 1 and Ar 1 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano and C 1 -C 2 -haloalkyl.

5. The compound of formula (I) according to claim 3 , wherein Q is a radical —C(O)—(O) m —R 2 , wherein R 2 is C 1 -C 4 -alkyl or C 3 -C 6 -cycloalkyl.

6. The compound of formula (I) according to claim 5 , wherein Ar 2 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano, nitro, C 1 -C 2 -haloalkyl, C 1 -C 2 -haloalkoxy or C 1 -C 2 -haloalkylthio.

7. The compound of formula (I) according to claim 6 , wherein the linker L 1 is of formula

wherein s and r are each independently an integer 1 or 2, r′ is an integer 0, 1 or 2, s′ is an integer 0, 1 or 2 and R is H or methyl.

8. The compound of formula (I) according to claim 7 , wherein the linker L 2 is a radical of formula

wherein r″ is 0 or 1, s′ is an integer 1 or 2 and R′ is H or methyl.

9. The compound of formula (I) according to claim 6 , wherein L 1 is a radical

and L 2 is a radical

10. The compound according to claim 1 of formula

wherein R 1 , R 2 , m, L 1 , L 2 , Z 1 , Z 2 and Ar 2 are each as defined in claim 1 .

11. The compound according to claim 1 of formula

wherein R 1 , Ar 1 , Ar 2 , L 1 , L 2 , Z 1 and Z 2 are each as defined in claim 1 .

12. The compound according to claim 1 of formula

wherein Q is 4-CF 3 -phenyl, 5-CF 3 -pyrid-2-yl, 6-CF 3 -pyrid-3-yl, —C(O)—O—tert-butyl or —C(O)-cyclopropyl;

Z 1 is N or CH;

Z 2 is N or CH;

L 1 is a radical,

L 2 is a radical

R 3 is CF 3 ; and R 3′ is cyano or nitro, or a physiologically acceptable salt thereof.

13. A method of controlling endoparasites, in warm-blooded animals, which comprises administering to the warm-blooded animals a veterinary effective amount of at least one compound of formula

wherein Z 1 and Z 2 are each independently N or CR 1′ ;

R 1 and R 1′ are each independently of the other H, halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 3 -haloalkoxyl, C 1 -C 4 -alkylthio, halo-C 1 -C 4 -alkylthio, SF 5 , amino, N-mono- or N,N-di-C 1 -C 4 -alkylamino, aminosulfonyl, N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl, N-mono- or N,N-di-halo-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonylamino, halo-C 1 -C 4 -alkylsulfonyl, halo-C 1 -C 4 -alkylsulfinyl, halo-C 1 -C 4 -alkylsulfonylamino or benzylsulfonylamino;

Q is Ar 1 or —C(O)—(O) m —R 2 ;

m is 0 or 1; R 2 is C 1 -C 6 -alkyl or C 3 -C 8 -cycloalkyl;

Ar 1 is (i) phenyl which is substituted by 1 to 2 same or different substituents selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxyl, C 1 -C 4 -alkylthio, halo-C 1 -C 4 -alkylthio, SF 5 , amino, N-mono- or N,N-di-C 1 -C 4 -alkylamino, aminosulfonyl, N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl, N-mono- or N,N-di-halo-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonylamino, benzylsulfonylamino, halo-C 1 -C 4 -alkylsulfonyl, halo-C 1 -C 4 -alkylsulfinyl and halodioxolyl; or is (ii) heteroaryl selected from the group consisting of 2-, 3- or 4-pyridyl and 2- or 3-thiophenyl which is each unsubstituted or substituted by methyl, ethyl, halogen, CF 3 or carboxy;

Ar 2 is phenyl which is substituted by 1 to 3 same or different substituents selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkylthio, halo-C 1 -C 4 -alkylthio, SF 5 , amino, N-mono- or N,N-di-C 1 -C 4 -alkylamino, aminosulfonyl, N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl, N-mono- or N,N-di-halo-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylsulfonyl, C 1 -C 4 -alkylsulfinyl, C 1 -C 4 -alkylsulfonylamino, benzylsulfonylamino, halo-C 1 -C 4 -alkylsulfonyl, halo-C 1 -C 4 -alkylsulfinyl and halodioxolyl;

L 1 is a bifunctional linker radical of formula

L 2 is a bifunctional linker radical of formula

A and B are each independently C 3 -C 8 -hetero-cycloalkylene or C 5 -C 10 -hetero-bicycloalkylene comprising two N-atoms, respectively which is each unsubstituted or substituted by C 1 -C 2 -alkyl;

A 1 , A 2 , and B 2 are each independently C 3 -C 8 -hetero-cycloalkylene comprising a N-atom, respectively;

R and R′ are each independently of the other H or C 1 -C 4 -alkyl;

or a physiologically acceptable salt thereof.

14. The method according to claim 13 , wherein R 1 and R 1′ are each independently of the other H, cyano, methyl or methoxy.

15. The method according to claim 13 , wherein Z 1 is N and Z 2 is CR 1′ .

16. The method according to claim 15 , wherein Q is Ar 1 and Ar 1 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano and C 1 -C 2 -haloalkyl.

17. The method according to claim 15 , wherein Q is a radical —C(O)—(O) m —R 2 , wherein R 2 is C 1 -C 4 -alkyl or C 3 -C 6 -cycloalkyl.

18. The method according to claim 17 , wherein Ar 2 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano, nitro, C 1 -C 2 -haloalkyl, C 1 -C 2 -haloalkoxy or C 1 -C 2 -haloalkylthio.

19. The method according to claim 18 , wherein the linker L 1 is of formula

wherein s and r are each independently an integer 1 or 2, r′ is an integer 0, 1 or 2, s′ is an integer 0, 1 or 2 and R is H or methyl.

20. The method according to claim 19 , wherein the linker L 2 is a radical of formula

wherein r″ is 0 or 1, s′ is an integer 1 or 2 and R′ is H or methyl.

21. The method according to claim 20 , wherein L 1 is a radical

and L 2 is a radical

22. The method according to claim 21 , wherein the at least one compound of formula (I) is a compound of formula

23. The method according to claim 13 , wherein the at least one compound of formula (I) is a compound of formula

wherein R 1 , Ar 1 , Ar 2 , L 1 , L 2 , Z 1 and Z 2 are each as defined in claim 13 .

24. The method according to claim 13 , wherein the at least one compound of formula (I) is a compound of formula

wherein Q is 4-CF 3 -phenyl, 5-CF 3 -pyrid-2-yl, 6-CF 3 -pyrid-3-yl, —C(O)—O—tert-butyl or —C(O)-cyclopropyl;

Z 1 is N or CH;

Z 2 is N or CH;

L 1 is a radical,

L 2 is a radical

R 3 is CF 3 ; and R 3′ is cyano or nitro, or a physiologically acceptable salt thereof.

Assignments (4)
CHANGE OF NAME Recorded Aug 23, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043363/0007 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: GAUVRY, NOËLLE; PAUTRAT, FRANCOIS
To: NOVARTIS ANIMAL HEALTH, INC.
Reel/Frame 038324/0993 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: NOVARTIS ANIMAL HEALTH, INC.
To: NOVARTIS AG
Reel/Frame 038325/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 038325/0048 →